Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.
Amydis has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Amydis's investors include Michael J. Fox Foundation, National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke.
Amydis is headquartered in San Diego, United States.
Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.
Amydis is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amydis — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/amydis. Accessed September 30, 2026.
VCBacked. (2026). Amydis — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/amydis
{{cite web |title=Amydis — Funding & Investors |url=https://www.vcbacked.co/company/amydis |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated